Top Industry News
- FDA- Postmarketing Adverse Event Reporting for Medical Products and Dietary Supplements During a Pandemic
- COVID-19: Regulatory Guidance in Connection with COVID-19 and Possible Impact on Assessment Times
- MDCG Offers Guidance on Safety Reporting for Device Studies Under MDR
- WHO Issues Guidance for Prequalified Products amid COVID-19